Bank of Montreal
GMAB icon

Bank of Montreal’s Genmab GMAB Stock Holding History

Bank of Montreal’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
52,043
-645
-1% -$17.1K ﹤0.01% 1910
2026
Q1 		$1.41M Sell
52,688
-164
-0.3% -$4.92K ﹤0.01% 1856
2025
Q4 		$1.63M Buy
52,852
+10,057
+24% +$313K ﹤0.01% 1741
2025
Q3 		$1.31M Buy
42,795
+2,739
+7% +$66.7K ﹤0.01% 1838
2025
Q2 		$828K Sell
40,056
-453
-1% -$9.3K ﹤0.01% 2004
2025
Q1 		$793K Buy
40,509
+8,400
+26% +$176K ﹤0.01% 1931
2024
Q4 		$670K Sell
32,109
-43,710
-58% -$960K ﹤0.01% 2071
2024
Q3 		$1.84M Sell
75,819
-1,168
-2% -$31.2K ﹤0.01% 1734
2024
Q2 		$2M Sell
76,987
-1,803
-2% -$51.1K ﹤0.01% 1663
2024
Q1 		$2.4M Buy
78,790
+14,985
+23% +$440K ﹤0.01% 1540
2023
Q4 		$2.04M Sell
63,805
-8,603
-12% -$270K ﹤0.01% 1675
2023
Q3 		$3.01M Buy
72,408
+39,246
+118% +$1.5M ﹤0.01% 1504
2023
Q2 		$1.3M Sell
33,162
-488
-1% -$19.5K ﹤0.01% 2036
2023
Q1 		$1.27M Sell
33,650
-1,979
-6% -$76.1K ﹤0.01% 1904
2022
Q4 		$1.51M Sell
35,629
-558
-2% -$23K ﹤0.01% 1936
2022
Q3 		$1.17M Buy
36,187
+585
+2% +$20.5K ﹤0.01% 2092
2022
Q2 		$1.15M Sell
35,602
-736
-2% -$23.8K ﹤0.01% 2220
2022
Q1 		$1.35M Sell
36,338
-2,684
-7% -$92.1K ﹤0.01% 2155
2021
Q4 		$1.57M Buy
39,022
+1,372
+4% +$57.2K ﹤0.01% 1705
2021
Q3 		$1.62M Buy
37,650
+1,337
+4% +$60K ﹤0.01% 2195
2021
Q2 		$1.48M Buy
36,313
+25,938
+250% +$1M ﹤0.01% 2234
2021
Q1 		$349K Buy
10,375
+1,195
+13% +$44.9K ﹤0.01% 2867
2020
Q4 		$386K Buy
9,180
+1,638
+22% +$61.2K ﹤0.01% 2851
2020
Q3 		$282K Buy
7,542
+3,031
+67% +$110K ﹤0.01% 2581
2020
Q2 		$161K Buy
4,511
+193
+4% +$5.26K ﹤0.01% 2836
2020
Q1 		$87K Sell
4,318
-3,570
-45% -$79.6K ﹤0.01% 2652
2019
Q4 		$177K Buy
+7,888
New +$172K ﹤0.01% 3224

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bank of Montreal's GMAB Position: Q2 2026 in Review

Bank of Montreal reduced its Genmab (GMAB) stake by 1.2% in Q2 2026, selling an estimated $17.1K and leaving 52,043 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Bank of Montreal first reported a position in GMAB in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.01M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Bank of Montreal held 52,043 shares of Genmab worth $1.43M as of Q2 2026.
  • Bank of Montreal sold 645 Genmab shares in Q2 2026, an estimated $17.1K.
  • Genmab made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1910 holding.
  • Bank of Montreal first reported a position in Genmab in Q4 2019 and has held it in 27 quarters since.
  • Bank of Montreal's Genmab position peaked at $3.01M in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.